Advertisement

 

 

Human T Cell Leukemia Virus Type 1: Persistence and Pathogenesis.

Human T Cell Leukemia Virus Type 1: Persistence and Pathogenesis.
Author Information (click to view)

Bangham CRM,


Bangham CRM, (click to view)

Bangham CRM,

Advertisement

Annual review of immunology 2017 11 16() doi 10.1146/annurev-immunol-042617-053222

Abstract

Human T cell leukemia virus type 1 (HTLV-1), also known as human T lymphotropic virus type 1, was the first exogenous human retrovirus discovered. Unlike the distantly related lentivirus HIV-1, HTLV-1 causes disease in only 5-10% of infected people, depending on their ethnic origin. But whereas HIV-1 infection and the consequent diseases can be efficiently contained in most cases by antiretroviral drug treatment, there is no satisfactory treatment for the malignant or inflammatory diseases caused by HTLV-1. The purpose of the present article is to review recent advances in the understanding of the mechanisms by which the virus persists in vivo and causes disabling or fatal diseases. Expected final online publication date for the Annual Review of Immunology Volume 36 is April 26, 2018. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

Submit a Comment

Your email address will not be published. Required fields are marked *

nine + twenty =

[ HIDE/SHOW ]